Meeder Asset Management’s Galectin Therapeutics GALT Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-3,817	Closed	-$9.12K	–	898
2024 Q1	$9.12K	Hold	3,817	–	–	﹤0.01%	565
2023 Q4	$6.34K	Hold	3,817	–	–	﹤0.01%	428
2023 Q3	$7.33K	Hold	3,817	–	–	﹤0.01%	439
2023 Q2	$5.5K	Hold	3,817	–	–	﹤0.01%	463
2023 Q1	$8.02K	Hold	3,817	–	–	﹤0.01%	515
2022 Q4	$4.31K	Sell	3,817 -1,818	-32%	-$2.42K	﹤0.01%	706
2022 Q3	$9K	Sell	5,635 -322	-5%	-$602	﹤0.01%	1357
2022 Q2	$7K	Sell	5,957 -2,037	-25%	-$2.93K	﹤0.01%	1502
2022 Q1	$13K	Buy	+7,994	New	+$15.5K	﹤0.01%	1446
2021 Q4	–	Sell	-7,783	Closed	-$30K	–	1614
2021 Q3	$30K	Buy	7,783 +2,866	+58%	+$9.71K	﹤0.01%	1273
2021 Q2	$16K	Buy	+4,917	New	+$17.5K	﹤0.01%	1527
2020 Q2	–	Sell	-186	Closed	–	–	2191
2020 Q1	$0	Buy	+186	New	+$453	﹤0.01%	2389
2019 Q4	–	Sell	-19	Closed	–	–	2319
2019 Q3	$0	Buy	+19	New	+$69	﹤0.01%	2186